<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="Learn how CDKL5 AAV9 gene therapy restores protein expression, meet the team, and explore the data guiding our path to first-in-human trials.">
    <title>About Us | CDKL5 Gene Therapy Coalition</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="css/style.css">
    <script async src="https://www.googletagmanager.com/gtag/js?id=UA-XXXXXXX-X"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);} // minimal GA placeholder
        gtag('js', new Date());
        gtag('config', 'UA-XXXXXXX-X');
    </script>
</head>
    <div data-include="inc/header.html"></div>

    <main>
        <div class="container">
            <section class="section fade-in">
                <span class="badge">Root-cause therapy</span>
                <h1>About our CDKL5 AAV9 program</h1>
                <p>We are a coalition of families, clinicians, and drug developers partnering to deliver a one-time gene therapy that addresses the fundamental deficit driving CDKL5 Deficiency Disorder (CDD). By transporting a functional CDKL5 gene directly into neurons, we aim to restore protein expression, stabilize circuitry, and reclaim developmental potential.</p>
            </section>

            <section class="section fade-in" aria-labelledby="mechanism-heading">
                <h2 id="mechanism-heading">How the therapy works</h2>
                <div class="card-grid">
                    <article class="card">
                        <h3>Targeted delivery</h3>
                        <p>Our therapy uses a special carrier to deliver a healthy <strong>CDKL5</strong> gene directly to brain cells, reaching key areas like the cortex and hippocampus.</p>
                    </article>
                    <article class="card">
                        <h3>Restoring Hope</h3>
                        <p>Once inside, the gene helps produce a vital protein that supports brain function, reduces seizures, and boosts development for kids with <strong>CDKL5 Deficiency Disorder</strong>.</p>
                    </article>
                    <article class="card">
                        <h3>Long-Lasting Effect</h3>
                        <p>This treatment is designed to work steadily over time, offering lasting benefits without altering a child’s natural DNA.</p>
                    </article>
                </div>
            </section>

            <section class="section fade-in" aria-labelledby="team-heading">
                <h2 id="team-heading">CDKL5 Gene Therapy Team</h2>

                <div class="team-group">
                    <h3 class="group-title">Clinical</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Nalin Gupta (University of California, San Francisco)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Heather Olson (Boston Children’s Hospital)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Adam Numis (University of California, San Francisco)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Tim Benke (Children’s Hospital, Colorado)</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">Preclinical</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Jacinthe Gingras</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Kruti Patel</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Ajay Bhargava (Shakti Bioresearch Labs)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Matthew Simon (Jackson Laboratory)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Vincent Pons (Jackson Laboratory)</h3>
                        </article>
                        <article class="card">
                            <h3>Tracy Johnson (Charles River Laboratory)</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">Design</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Lester Suarez</h3>
                        </article>
                        <article class="card">
                            <h3>Ilya Musavey</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">Manufacturing</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Paul Herzich</h3>
                        </article>
                        <article class="card">
                            <h3>Sarah Caffey (MaticaBio)</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">Scientific Advisors</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Lauren Black (Charles River Laboratory)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Michael Templin (Charles River Laboratory)</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Gai Ayalon</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Cecilia Lo (University of Pittsburgh)</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">Regulatory</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Tim Cote</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Sangeeta Joshi</h3>
                        </article>
                    </div>
                </div>

                <div class="team-group">
                    <h3 class="group-title">India Clinical Team</h3>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Dr. Sheffali Gulati</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Lokesh Lingappa</h3>
                        </article>
                        <article class="card">
                            <h3>Dr. Prasanthi Aripiralla</h3>
                        </article>
                    </div>
                </div>
            </section>

            <section class="section fade-in" aria-labelledby="data-heading">
                <!--
                <section class="section fade-in" aria-labelledby="data-heading">
                    <h2 id="data-heading">Preclinical evidence at a glance</h2>
                    <div class="card-grid">
                        <article class="card">
                            <h3>Neuron targeting</h3>
                            <ul class="info-list">
                                <li>i.c.v. dosing transduced ≥50% of neurons in cortex, hippocampus, and thalamus.[1]</li>
                                <li>Improved hindlimb clasping, open-field exploration, and contextual fear conditioning.[5]</li>
                            </ul>
                        </article>
                        <article class="card">
                            <h3>Functional recovery</h3>
                            <ul class="info-list">
                                <li>UX055 restored motor and cognitive function in CDKL5 knockout mouse models.[2]</li>
                                <li>Human induced pluripotent stem cell organoids showed corrected hyperexcitability.[2]</li>
                            </ul>
                        </article>
                        <article class="card">
                            <h3>Safety and biodistribution</h3>
                            <ul class="info-list">
                                <li>Favorable biodistribution compared with intrathecal delivery, reducing peripheral exposure.[5]</li>
                                <li>No vector-related toxicity observed at efficacious doses (3e11–5e11 vg/g brain).[1]</li>
                            </ul>
                        </article>
                    </div>
                </section>
                -->

            <section class="section fade-in" aria-labelledby="milestones-heading">
                <!--
                <section class="section fade-in" aria-labelledby="milestones-heading">
                    <h2 id="milestones-heading">Milestones</h2>
                    <ul class="info-list">
                        <li>April 2024: Completed vector design freeze and pre-IND meeting feedback integration.</li>
                        <li>Q4 2024: Launch translational toxicology in partnership with CRO network.</li>
                        <li>Q2 2025: Manufacture GMP batch and finalize release assays.</li>
                        <li>Q2 2026: Target first participant dosing pending $3.5M fundraising goal.</li>
                    </ul>
                </section>
                -->
        </div>
    </main>

    <div data-include="inc/footer.html"></div>

    <script src="js/includes-loader.js" defer></script>
    <script src="js/script.js" defer></script>
</body>
</html>
